ChemoMetec A/S

Price Chart

Risk-Adjusted Performance

Also Listed On

ChemoMetec A/S (CHEMM) Price Performance

ChemoMetec A/S (CHEMM) trades on Nasdaq Copenhagen in DKK. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at DKK346.00, down 1.14% from the previous close.

Over the past year, CHEMM has traded between a low of DKK236.80 and a high of DKK792.00. The stock has lost 27.9% over this period. It is currently 56.3% below its 52-week high.

ChemoMetec A/S has a market capitalization of $5.27B, with a price-to-earnings ratio of 29.78 and a dividend yield of 2.31%.

About ChemoMetec A/S

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops XcytoMatic 30 cell counter and Xcyto 5, a versatile cell analyzer. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.